|1.||Finkel, Mitchell S: 4 articles (07/2012 - 01/2006)|
|2.||Nath, Avindra: 4 articles (04/2007 - 08/2004)|
|3.||Herbein, Georges: 3 articles (01/2013 - 07/2005)|
|4.||Chen, Fangping: 3 articles (07/2012 - 12/2008)|
|5.||Kan, Hong: 3 articles (03/2009 - 01/2006)|
|6.||Bryant, Joseph: 2 articles (03/2015 - 01/2013)|
|7.||Kent, Stephen J: 2 articles (02/2013 - 12/2007)|
|8.||Lewis, William: 2 articles (07/2012 - 03/2009)|
|9.||Payne, Rebecca: 2 articles (04/2009 - 01/2007)|
|10.||Brander, Christian: 2 articles (04/2009 - 01/2007)|
|1.||Acquired Immunodeficiency Syndrome (AIDS)
01/01/2013 - "Since the elucidation of molecular mechanism of HIV proteins should lead to remedy of AIDS, the author has been engaged in the study of HIV protein in the past decade. "
11/01/2005 - "New vaccine candidates exploiting the rational combination of regulatory and structural HIV gene products are being developed within the program of the AIDS Vaccine Integrated Project (AVIP) and will be tested in comparative preclinical and clinical trials with the ultimate goal of selecting proper candidates for advanced clinical testing in developing countries."
03/01/2001 - "This review will discuss the validity of the apoptosis hypothesis in HIV disease and the potential mechanism(s) that HIV proteins perform in the progressive T cell depletion observed in AIDS pathogenesis."
11/30/1994 - "Interference with T cell activation signals by Human immunodeficiency virus (HIV) gene products is suggested to contribute to the impairment of immune functions observed in AIDS. "
10/01/1994 - "T epitope mapping in human immunodeficiency virus proteins provides a useful tool for AIDS vaccine design. "
11/07/2014 - "Using wide ranges of parameter values, we observed the following: (1) a phenomenological description of the viral productive and latent cell phenotypes is obtained by bistable and bimodal dynamics, (2) biochemical noise reduces the probability that an infected cell adopts the latent state, (3) the effects of the innate immune response enhance the HIV latency state, (4) the conditions of the cell before infection affect the latent phenotype, i.e., the existing expression of cell restriction factors propitiates HIV latency, and existing expression of HIV proteins reduces HIV latency. "
04/01/2014 - "However, structural HIV proteins and, more specifically, the mechanisms that involve the virus in cell infection and replication are now also considered therapeutic targets. "
02/01/2014 - "We have designed lentiviral vectors encoding secreted anti-HIV proteins to protect both gene-modified and unmodified cells from infection. "
01/01/2009 - "Among HIV proteins, Nef is considered a promising target for the formulation of a multi-component vaccine due to its implication in the first steps of viral infection. "
01/01/2007 - "The probiotic organism Lactobacillus reuteri RC-14 which safely colonizes the human vagina and prevents microbial infections, has been genetically modified to produce anti-HIV proteins which were capable of blocking the three main steps of HIV entry into human peripheral blood mononuclear cells. "
|3.||HIV Infections (HIV Infection)
01/01/2013 - "In this review, we will describe how HIV infection is modulated by signaling mediated through members of TNF and TNFR superfamily and in turn how these latter could be targeted by HIV proteins. "
07/01/2012 - "Potential mechanisms responsible for myocardial dysfunction following HIV infection include direct effects of HIV proteins. "
03/08/2005 - "The pathogenesis of DSP is unknown, although both HIV proteins and products of immune activation triggered by HIV infection have been implicated. "
07/01/2004 - "The alteration in apoptotic homeostasis induced by HIV, HIV proteins, the host response to HIV infection and/or HIV therapies either promote apoptosis or inhibit apoptotic signals depending on the cellular context. "
01/01/2003 - "Potential explanations include an alteration of the CNS milieu by HIV facilitating JC viral entry into the brain and activation of the JCV by HIV proteins, e.g., tat, and by inflammatory byproducts of HIV infection. "
|4.||AIDS Dementia Complex
11/01/2006 - "A broad range of studies using either brain or cerebrospinal fluid (CSF) tissues from well-characterized patients with HIV dementia, animal models, and in vitro studies from several laboratories using HIV-infected cells or HIV proteins provide overwhelming evidence for oxidative stress in mediating neuronal injury in this patient population. "
11/01/2009 - "Many human immunodeficiency virus (HIV) proteins including Tat are produced by HIV-infected astrocytes and secreted into the brain resulting in extensive neuronal damage that contributes to the pathogenesis of HIV dementia. "
12/01/2002 - "Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia."
01/01/2012 - "Cerebral damage developed through latent and acute periods also known as HIV-encephalopathy, HIV-associated neurocognitive dysfunction etc. Cerebral lesions are caused by a variety of chemical agents from pro-inflammatory cytokines to toxic HIV-proteins resulting in development of HIV-dementia through several years. "
04/01/2007 - "Human immunodeficiency virus (HIV) proteins Tat and gp120 have been implicated in the pathogenesis of HIV dementia by various mechanisms, including down-regulation of excitatory amino acid transporter-2 (EAAT2), which is responsible for inactivation of synaptic glutamate. "
07/15/2000 - "The frequencies of CD8+ T cells specific to the majority of HIV gene products were measured by flow cytometric detection of intracellular IFN-gamma in response to HIV-vaccinia recombinant-infected autologous B cells. "
05/01/1990 - "This virus, together with another vaccinia recombinant encoding biologically active HIV envelope glycoprotein gp160, allowed us to study CD4/gp160-mediated cell-cell fusion in a wide variety of human and nonhuman cells in the absence of other HIV proteins. "
11/01/2001 - "The frequencies of CD8(+) T cells specific to the majority of HIV gene products were measured by flow cytometric detection of intracellular interferon-gamma (IFN-gamma) in response to HIV-vaccinia recombinant infected autologous B cells. "
|2.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|3.||HIV Envelope Protein gp160
|7.||Proteins (Proteins, Gene)
|8.||DNA (Deoxyribonucleic Acid)
|10.||Glutamic Acid (Glutamate)
|1.||Highly Active Antiretroviral Therapy (HAART)